Aterian, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Aterian, Inc. has entered into a definitive agreement to sell its marquee brands for $18 million and secured a $7 million capital infusion to address liquidity concerns.
NASDAQ
Aterian, Inc. reported a significant decline in net revenue and increased net losses for Q3 2025, citing macroeconomic pressures and new tariffs on Chinese imports.
NASDAQ
Aterian, Inc. reported a significant decline in Q2 revenue and increased net loss, with its auditor raising substantial doubt about the company's ability to continue as a going concern.
NASDAQ
Aterian Inc.'s Q1 2025 results reveal a revenue decrease alongside ongoing cost reduction initiatives and concerns about its ability to continue as a going concern.
NASDAQ
Aterian Inc. reported a decrease in revenue for the third quarter of 2024, alongside a strategic shift focusing on profitable products and cost reductions.
NASDAQ
Aterian, Inc. reported its second quarter 2024 results, highlighting a strategic shift towards profitable products and cost-cutting measures, alongside a decrease in revenue and a net loss.
NASDAQ
Aterian Inc. experienced a significant revenue decrease in the first quarter of 2024, alongside a strategic shift focusing on core, profitable products and cost reductions.